BPC-157 + TB-500 Refill Cartridge specifications and research profile
Specifications summary
| Designation | Two-component peptide research blend |
|---|---|
| Also known as | BPC-157 + TB-500 research blend |
| Sequence / composition | 15mg BPC-157 + 15mg TB-500 |
| Strength | 30mg 3ml cartridge |
| Presentation | Refill cartridge |
| Purity | 99%+ HPLC |
| Storage | Store refrigerated at 2-8 C, protected from light. |
| COA | View BPC-157/TB-500 10mg component-vial COA - three vials per prepared product |
Description and research context
BPC-157 + TB-500 is a documented combination of two research components rather than a single molecular entity. The combined format is intended for controlled blend-versus-component comparison.
Published component studies include BPC-157 experiments involving fibroblast migration and FAK-paxillin signalling, plus thymosin-beta-derived peptide studies involving actin binding and cell migration. These component findings do not establish a unified mechanism for the blend.
Applications in research
- Blend-versus-component analytical and cell-based comparisons
- Fibroblast migration and FAK-paxillin pathway assays
- Actin-binding, cytoskeletal and cell-motility research models
Precautions and interpretation
For controlled laboratory research only. Not for human or veterinary use. The cited findings come from specific biochemical, cellular, structural or preclinical models and must not be treated as usage guidance or evidence of a defined outcome outside those models.
BPC-157 + TB-500 Refill Cartridge research record
Clear product, batch, storage, dispatch and document information for this refill cartridge.
Research context
A blend of BPC-157 and TB-500 for laboratory research into cell movement and tissue-repair pathways.
Product record
The listing identifies the presentation, specification, storage record, dispatch status, and COA availability for the relevant product or batch.
Use restriction
For laboratory research use only. Not for human or veterinary consumption. No use instructions or therapeutic guidance is provided.